360p PLUS25 Jul 2020 15:03
The Guardian 24 jULY
Mark Brewer, an analyst at FinnCap, Synairgen’s house broker, said: “Valuing the Covid-19 opportunity is nigh on impossible; however, we upgrade our target price to 360p but recognise this could go substantially higher, based on upcoming discussions with regulators,”